SVRA4:05 PMSavara Reports Second Quarter 2026 Financial Results and Provides Business Updatesavarapharma.com
SVRA8:05 AMSavara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041savarapharma.com